Deerland Enzymes & Probiotics has been granted a Natural Product Number (NPN) for Bacillus subtilis DE111, a genome sequenced and clinically studied probiotic strain that supports gut health. This new product license issuance by the Natural Health Products Directorate of Health Canada (NPN 80077102) allows DE111 to be sold throughout Canada.
Join Deerland at Booth N41 where we’ll be highlighting our clinically supported branded products.
Deerland is pleased to announce that it has completed the audit for ISO 9001:2015 certification by SGS, the world’s leading inspection, verification, testing and certification company.
The International Organization for Standardization (ISO) is globally recognized for its high-quality standards, which cover a wide range of industries and processes that aim to raise the bar for corporate performance and continuous improvement. The ISO 9001:2015 standard is the latest for quality management systems. For a company to achieve this certification, it must show a commitment to excellence in the areas of process organization, quality control, quality assurance, resource management, customer satisfaction, continuous improvement and much more.
Kennesaw, Georgia, based Deerland Enzymes and Probiotics is proud to announce the launch of Digestible, an educational content portal within DeerlandEnzymes.com.
The enzymes and probiotics market makes up a large part of the growing $37 billion dietary supplement industry, and its rise is driven by consumer preferences for quality supplements. According to Euromonitor International, “dietary supplements and health and wellness products positioned for digestive health are among the most popular platforms by value.”
Washington, D.C., January 9, 2017—The Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement and functional food industry, and the International Probiotics Association (IPA), an international membership organization of probiotic companies, today announce the development of scientifically-based best practices guidelines for the labeling, storing, and stability testing of dietary supplements and functional foods containing probiotics. As probiotics are quickly gaining popularity, the guidelines are designed to ensure probiotic manufacturers can consistently create high-quality products that consumers can be confident in.
If current trends hold true, probiotic dietary supplements will be the fastest-growing supplement category in North America in 2016–2021, according to a presentation by market researcher Euromonitor at October’s SupplySide West trade show. During this time frame, North America’s probiotic supplement growth (55%) will also outpace the rest of the world’s (38%).
Read more at nutritionaloutlook.com.
Deerland Enzymes is pleased to announce the official opening of its new, state-of-the-art facility dedicated exclusively to manufacturing probiotic-based supplement products. Production at the new Deerland Probiotics facility has begun, and the company celebrated with a ribbon-cutting ceremony this week.
FDA is expected to issue a revised draft document governing new dietary ingredient (NDI) notifications to the agency.
Industry sources described release of the document as “imminent” and said it could be unveiled in the coming weeks in response to criticisms that the July 2011 guidance poses undue burdens to companies and is contrary to the 1994 Dietary Supplement Health and Education Act (DSHEA).
Read more at naturalproductsinsider.com.